🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
KOD
$KOD
🔒 US EquitiesKodiak Sciences Inc
AVG HISTORICAL GAP
+0.90%
MAX GAP RECORD
+9.51%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $KOD
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$KOD
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 12, 2026 Earnings Release 2026-11-12 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 19, 2026 Earnings Release 2026-08-19 (BEFORE OPEN) |
+2.63%
|
| Mar 31, 2026 Earnings Release 2026-03-31 (AFTER CLOSE) |
+4.35%
|
| Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE) |
-2.28%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
+9.51%
|
| May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE) |
-3.05%
|
| Mar 27, 2025 Earnings Release 2025-03-27 (AFTER CLOSE) |
-2.94%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE) |
+0.75%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.5%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (2)
📖 Intelligence Summary
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗